This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 1 month ago.

  • Author
    Posts
  • #20800

    Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses the first patient dosed in a Phase 2b study testing inhaled RVT-1601 for IPF cough.

    What do you think of this news?

    Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account